GEP20043313B - Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility - Google Patents

Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility

Info

Publication number
GEP20043313B
GEP20043313B GE4769A GEAP2000004769A GEP20043313B GE P20043313 B GEP20043313 B GE P20043313B GE 4769 A GE4769 A GE 4769A GE AP2000004769 A GEAP2000004769 A GE AP2000004769A GE P20043313 B GEP20043313 B GE P20043313B
Authority
GE
Georgia
Prior art keywords
endometriosis
infertility
treatment
pharmaceutical composition
improving fertility
Prior art date
Application number
GE4769A
Other languages
English (en)
Inventor
William J Bologna
Dominique De Ziegler
Howard L Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of GEP20043313B publication Critical patent/GEP20043313B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GE4769A 1999-10-05 2000-10-04 Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility GEP20043313B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25

Publications (1)

Publication Number Publication Date
GEP20043313B true GEP20043313B (en) 2004-03-10

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
GE4769A GEP20043313B (en) 1999-10-05 2000-10-04 Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility

Country Status (28)

Country Link
EP (1) EP1220667B1 (enExample)
JP (2) JP2003510354A (enExample)
KR (1) KR100738724B1 (enExample)
CN (1) CN1218694C (enExample)
AR (1) AR028487A1 (enExample)
AT (1) ATE271860T1 (enExample)
AU (1) AU780736B2 (enExample)
BR (1) BR0014548A (enExample)
CA (1) CA2385974C (enExample)
CO (1) CO5251423A1 (enExample)
DE (1) DE60012554T2 (enExample)
DK (1) DK1220667T3 (enExample)
ES (1) ES2223581T3 (enExample)
GE (1) GEP20043313B (enExample)
HK (1) HK1044120B (enExample)
HU (1) HU225990B1 (enExample)
IL (2) IL148784A0 (enExample)
MA (1) MA25501A1 (enExample)
MX (1) MXPA02003453A (enExample)
MY (1) MY129518A (enExample)
NO (1) NO329663B1 (enExample)
NZ (1) NZ518429A (enExample)
PE (1) PE20010742A1 (enExample)
PT (1) PT1220667E (enExample)
TR (1) TR200200899T2 (enExample)
TW (1) TWI280877B (enExample)
UA (1) UA74168C2 (enExample)
WO (1) WO2001024788A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
CN102906103A (zh) * 2010-03-22 2013-01-30 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
MX363640B (es) 2012-05-31 2019-03-28 Repros Therapeutics Inc Formulaciones y metodos para la administracion vaginal de antiprogestinas.
US9545411B2 (en) 2012-11-02 2017-01-17 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
NO20021591D0 (no) 2002-04-04
MXPA02003453A (es) 2002-08-20
AR028487A1 (es) 2003-05-14
DK1220667T3 (da) 2004-12-06
EP1220667A2 (en) 2002-07-10
NO20021591L (no) 2002-05-28
WO2001024788A2 (en) 2001-04-12
AU780736B2 (en) 2005-04-14
WO2001024788A3 (en) 2001-12-06
BR0014548A (pt) 2002-06-04
MY129518A (en) 2007-04-30
HUP0203050A3 (en) 2006-02-28
CA2385974A1 (en) 2001-04-12
HK1044120A1 (en) 2002-10-11
CA2385974C (en) 2010-01-26
JP2003510354A (ja) 2003-03-18
PT1220667E (pt) 2004-11-30
ATE271860T1 (de) 2004-08-15
IL148784A (en) 2006-12-31
CN1377264A (zh) 2002-10-30
DE60012554T2 (de) 2005-11-24
KR20020062285A (ko) 2002-07-25
ES2223581T3 (es) 2005-03-01
NZ518429A (en) 2004-02-27
DE60012554D1 (de) 2004-09-02
HK1044120B (en) 2004-12-17
NO329663B1 (no) 2010-11-29
MA25501A1 (fr) 2002-07-01
TWI280877B (en) 2007-05-11
KR100738724B1 (ko) 2007-07-12
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
UA74168C2 (uk) 2005-11-15
PE20010742A1 (es) 2001-07-19
CO5251423A1 (es) 2003-02-28
IL148784A0 (en) 2002-09-12
HU225990B1 (en) 2008-02-28
EP1220667B1 (en) 2004-07-28
TR200200899T2 (tr) 2002-07-22
CN1218694C (zh) 2005-09-14
HUP0203050A2 (hu) 2003-02-28

Similar Documents

Publication Publication Date Title
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
ZA954548B (en) Monoamine diamide thiol-containing metal chelating agents
GEP20063885B (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
MY119403A (en) Novel compounds with analgesic effect.
GEP20033079B (en) Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency
TW355683B (en) Composition containing micronized nebivolol
PL327735A1 (en) Novel substituted derivatives of imidazole
MY106315A (en) Pharmaceutical agents
PL347671A1 (en) Compounds and compositions for delivering active agents
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
GEP20032896B (en) 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
BG105534A (en) 5ht1 means and method for the treatment of migraine
HU229458B1 (en) Pharmaceutical compositions containing zolmitriptan
MX9706647A (es) Composiciones farmaceuticas que comprenden inhibidores de oxidasa b de monoamina.
YU13301A (sh) Muskarinski agonisti i antagonisti
EP0663835A1 (en) USE OF PARATHORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY PROBLEMS.
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
GEP20043313B (en) Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
BG105204A (en) Salts of paroxetine